We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.37B
AUM Growth
+$142M
Cap. Flow
+$10.8M
Cap. Flow %
0.79%
Top 10 Hldgs %
29.55%
Holding
194
New
9
Increased
52
Reduced
83
Closed
4

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$8.55M
2
PYPL icon
PayPal
PYPL
+$1.23M
3
SNY icon
Sanofi
SNY
+$1.23M
4
NVS icon
Novartis
NVS
+$1.08M
5
PPLI
People Inc
PPLI
+$918K

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$1.59M
2
BC icon
Brunswick
BC
+$1.26M
3
MSFT icon
Microsoft
MSFT
+$1.23M
4
DVN icon
Devon Energy
DVN
+$880K
5
CTSH icon
Cognizant
CTSH
+$748K

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 17.1%
3 Industrials 13.26%
4 Financials 11.2%
5 Consumer Staples 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
101
Kimberly-Clark
KMB
$37.5B
$1.01M 0.07%
7,425
MCD icon
102
McDonald's
MCD
$194B
$998K 0.07%
3,787
-38
-1% -$10K
WAT icon
103
Waters Corp
WAT
$37.7B
$997K 0.07%
2,910
AMZN icon
104
Amazon
AMZN
$2.48T
$983K 0.07%
11,701
+90
+0.8% +$8.89K
ABBV icon
105
AbbVie
ABBV
$465B
$955K 0.07%
5,912
-3
-0.1% -$460
PM icon
106
Philip Morris
PM
$312B
$944K 0.07%
9,325
ORCL icon
107
Oracle
ORCL
$346B
$911K 0.07%
11,146
+112
+1% +$8.51K
NVO
108
Novo Nordisk
NVO
$225B
$902K 0.07%
13,334
FUL icon
109
H.B. Fuller
FUL
$3.07B
$866K 0.06%
12,094
AZN icon
110
AstraZeneca
AZN
$267B
$859K 0.06%
6,332
-1
-0% -$125
GMAB icon
111
Genmab
GMAB
$17.8B
$853K 0.06%
20,118
+9,908
+97% +$408K
J icon
112
Jacobs Solutions
J
$16.6B
$842K 0.06%
8,479
+150
+2% +$14.7K
BP icon
113
BP
BP
$107B
$816K 0.06%
23,353
+360
+2% +$12K
NEE icon
114
NextEra Energy
NEE
$186B
$812K 0.06%
9,708
+500
+5% +$40.4K
V icon
115
Visa
V
$697B
$801K 0.06%
3,854
-134
-3% -$27K
BDX icon
116
Becton Dickinson
BDX
$45.8B
$786K 0.06%
3,090
-59
-2% -$13.9K
IWB icon
117
iShares Russell 1000 ETF
IWB
$47.9B
$784K 0.06%
3,723
-841
-18% -$178K
VHT icon
118
Vanguard Health Care ETF
VHT
$18.6B
$755K 0.06%
3,045
HUBB icon
119
Hubbell
HUBB
$25.6B
$755K 0.06%
3,217
VPL icon
120
Vanguard FTSE Pacific ETF
VPL
$7.89B
$737K 0.05%
11,450
TGT icon
121
Target
TGT
$65.5B
$718K 0.05%
4,816
DE icon
122
Deere & Co
DE
$173B
$613K 0.04%
1,429
-8
-0.6% -$3.25K
DD icon
123
DuPont de Nemours
DD
$19B
$576K 0.04%
6,681
MTD icon
124
Mettler-Toledo International
MTD
$28.1B
$535K 0.04%
370
CMCSA icon
125
Comcast
CMCSA
$85.8B
$514K 0.04%
14,700
+200
+1% +$6.62K

Similar funds

Grandfield & Dodd's Q4 2022 Portfolio in Review

As of Q4 2022, Grandfield & Dodd held 194 positions worth $1.37B, up 12% from $1.22B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q4 2022 filing shows 9 new, 52 increased, 83 reduced and 4 closed positions. Its largest new stake was Duke Energy: 2,659 shares worth $274K. The largest sale was Synopsys, an estimated $1.59M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q4 2022 buy was Duke Energy: 2,659 shares worth $274K.
  • Grandfield & Dodd added most to GE Aerospace in Q4 2022, an estimated $8.55M increase.
  • Grandfield & Dodd's biggest Q4 2022 reduction was Synopsys, cutting an estimated $1.59M.
  • Grandfield & Dodd fully exited CarMax in Q4 2022, selling an estimated $240K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.37B portfolio in Q4 2022.
  • Grandfield & Dodd opened 9 new positions and closed 4 in Q4 2022.
  • Grandfield & Dodd's portfolio value rose 12% quarter-over-quarter to $1.37B.

Based on Grandfield & Dodd's 13F filing for Q4 2022, filed 20 Jan 2023.